CordenPharma buys Ancora; Catalent expands in China; Indian regulators slap API maker;

> The U.S. division of CordenPharma, a contract manufacturer based in Plankstadt, Germany, has acquired Woburn, MA-based Ancora Pharmaceuticals, a carbohydrate synthesis company. Release

> The FDA is requesting label changes and single-use packaging for over-the-counter topical antiseptic products to decrease the risk of infections. Release

> Catalent Pharma Solutions has completed construction and validation of its 31,000-square-foot clinical supply facility in Shanghai, China. Report

> Wacker Biotech has a deal to buy from BioNet Ventures its Scil Proteins Production division, which operates a fermenter in Halle, Germany, with a capacity of up to 1,500 liters. Report

> San Diego-based Formex has launched cytotoxic and potent pharmaceuticals dedicated suites at its 80,000-square-foot facility in Torrey Pines, CA. Report

And Finally... The Drug Controller General of India has accused Puducherry-based contract manufacturer GuruFcure, which claims to supply some large companies, with submitting fabricated data about 7 combination drugs for which it is seeking approval. Story